Latest / The AI in Business Podcast
Using Artificial Intelligence to Unlock Hidden Insights in Genomic Research - with Dr. Mark Kiel of Genomenon
Today's guest is Dr. Mark Kiel, Chief Science Officer and Founder at Genomenon. Genomenon is a genomics intelligence company that unlocks real-world evidence from biomedical literature to help pharmaceutical and clinical diagnostics companies inform precision medicine, accelerate patient diagnosis, and guide trial design and label expansion. Mark joins Emerj Editorial Director Matthew DeMello to explore how AI can streamline the extraction, organization, and interpretation of genomic and clinical data, enabling faster, more accurate decision-making in pharmaceutical R&D. He also shares…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.